Merck Off The Hook In Fosamax Fracture Suit, Judge Rules

Law360, Los Angeles (June 27, 2013, 9:34 PM EDT) -- A New Jersey federal judge on Thursday said claims that Merck & Co. failed to warn a consumer of the possible risk of femur fractures from the use of its bone drug Fosamax are preempted under federal law because the U.S. Food and Drug Administration refused to strengthen the drug's label the year the consumer was injured.

U.S. District Judge Joel A. Pisano granted Merck summary judgment on the failure to warn question Thursday, effectively terminating Bernadette Glynn's lawsuit against the company. Glynn claimed she suffered a...
To view the full article, register now.




Case Information

Case Title

MOLNAR et al v. MERCK & CO., INC.

Case Number



New Jersey

Nature of Suit

Personal Inj. Prod. Liability


Freda L. Wolfson

Date Filed

January 2, 2008

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.